Oral Health, Caries Risk Profiles, and Oral Microbiome of Pediatric Patients with Leukemia Submitted to Chemotherapy.


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2021
Historique:
received: 17 11 2020
revised: 29 12 2020
accepted: 06 01 2021
entrez: 3 2 2021
pubmed: 4 2 2021
medline: 25 5 2021
Statut: epublish

Résumé

Chemotherapy is the primary treatment modality used for patients with acute lymphoblastic leukemia (ALL), but inevitably causes microbiota-related oral complications. This study is aimed at investigating the effects of chemotherapy on oral health status, caries risk, and oral microbiome in pediatric patients with ALL. Thirty-nine children with ALL receiving chemotherapy were enrolled, and a gender-, age-, dentition stage, and socioeconomic class matched healthy counterpart were recruited. Demographic information and overall health condition were obtained through the questionnaire and medical records. Oral examination was performed to assess caries and salivary status, plaque index, and other oral manifestations. Cariogram was used to assess the overall caries risk. Supragingival samples of thirteen ALL subjects and their counterparts were randomly selected to perform a 16S ribosomal RNA gene 454 pyrosequencing. Raw sequence data were screened, trimmed, and filtered using Seqcln and MOTHUR. The prevalence of dental caries, gingivitis, oral mucositis, xerostomia, and candidiasis in ALL groups was higher than that of the control group ( ALL patients receiving chemotherapy demonstrated compromised oral health, high caries risk, alteration of caries-related factors, and dysbiosis of oral microbiota. These findings may be of clinical importance in developing better strategies for personalized preventive management of oral diseases for pediatric children with ALL.

Sections du résumé

BACKGROUND BACKGROUND
Chemotherapy is the primary treatment modality used for patients with acute lymphoblastic leukemia (ALL), but inevitably causes microbiota-related oral complications. This study is aimed at investigating the effects of chemotherapy on oral health status, caries risk, and oral microbiome in pediatric patients with ALL.
METHODS METHODS
Thirty-nine children with ALL receiving chemotherapy were enrolled, and a gender-, age-, dentition stage, and socioeconomic class matched healthy counterpart were recruited. Demographic information and overall health condition were obtained through the questionnaire and medical records. Oral examination was performed to assess caries and salivary status, plaque index, and other oral manifestations. Cariogram was used to assess the overall caries risk. Supragingival samples of thirteen ALL subjects and their counterparts were randomly selected to perform a 16S ribosomal RNA gene 454 pyrosequencing. Raw sequence data were screened, trimmed, and filtered using Seqcln and MOTHUR.
RESULTS RESULTS
The prevalence of dental caries, gingivitis, oral mucositis, xerostomia, and candidiasis in ALL groups was higher than that of the control group (
CONCLUSIONS CONCLUSIONS
ALL patients receiving chemotherapy demonstrated compromised oral health, high caries risk, alteration of caries-related factors, and dysbiosis of oral microbiota. These findings may be of clinical importance in developing better strategies for personalized preventive management of oral diseases for pediatric children with ALL.

Identifiants

pubmed: 33532491
doi: 10.1155/2021/6637503
pmc: PMC7834790
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6637503

Informations de copyright

Copyright © 2021 Yan Wang et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

ISME J. 2012 Jan;6(1):1-10
pubmed: 21716312
Int Dent J. 2018 Aug;68(4):221-226
pubmed: 29572813
J Periodontol. 2011 Sep;82(9):1295-303
pubmed: 21284544
Microb Ecol. 2010 Oct;60(3):677-90
pubmed: 20614117
J Clin Pediatr Dent. 2018;42(3):225-230
pubmed: 29698138
Cancer Immunol Immunother. 2000 Jun;49(3):165-72
pubmed: 10881696
J Bacteriol. 2010 Oct;192(19):5002-17
pubmed: 20656903
Angle Orthod. 2012 Mar;82(2):267-74
pubmed: 21827234
J Infect Dis. 1978 Jan;137(1):14-29
pubmed: 624850
J Clin Oncol. 2014 Mar 20;32(9):949-59
pubmed: 24550419
Indian J Med Paediatr Oncol. 2014 Jan;35(1):36-9
pubmed: 25006282
PLoS Comput Biol. 2009 Apr;5(4):e1000352
pubmed: 19360128
NCI Monogr. 1990;(9):21-6
pubmed: 2188156
BMC Oral Health. 2019 Nov 21;19(1):255
pubmed: 31752810
Nat Rev Cancer. 2018 Aug;18(8):471-484
pubmed: 29784935
Int J Pediatr Otorhinolaryngol. 2007 Nov;71(11):1681-5
pubmed: 17850887
J Dent. 2017 Jul;62:25-30
pubmed: 28456556
Braz J Otorhinolaryngol. 2014 Jan-Feb;80(1):78-85
pubmed: 24626896
Genome Med. 2017 Feb 28;9(1):21
pubmed: 28245856
Angle Orthod. 2009 Mar;79(2):323-30
pubmed: 19216589
J Clin Pediatr Dent. 2010 Spring;34(3):275-9
pubmed: 20578668
Eur Arch Paediatr Dent. 2020 Feb;21(1):129-136
pubmed: 31214964
Microbiome. 2019 Apr 25;7(1):66
pubmed: 31018870
J Natl Cancer Inst Monogr. 2001;(29):31-6
pubmed: 11694563
Support Care Cancer. 2018 Jan;26(1):155-174
pubmed: 28735355
J Clin Pediatr Dent. 2008 Summer;32(4):319-24
pubmed: 18767465
PLoS One. 2018 Jul 9;13(7):e0199574
pubmed: 29985926
Acta Odontol Scand. 1964 Feb;22:121-35
pubmed: 14158464
Community Dent Oral Epidemiol. 2005 Aug;33(4):256-64
pubmed: 16008632
Pediatr Dent. 2019 Sep 15;41(5):391-399
pubmed: 31648671
PLoS One. 2014 Jul 15;9(7):e102116
pubmed: 25025462
Support Care Cancer. 2010 Aug;18(8):1007-21
pubmed: 20449756
BMC Oral Health. 2018 Jul 16;18(1):123
pubmed: 30012136
Int J Oral Sci. 2013 Mar;5(1):21-5
pubmed: 23538641
Oral Oncol. 2010 Jun;46(6):464-7
pubmed: 20308007
J Oral Pathol Med. 2015 Aug;44(7):483-9
pubmed: 25243950
J Clin Pediatr Dent. 2011 Spring;35(3):319-23
pubmed: 21678678
Rev Med Inst Mex Seguro Soc. 2018 Mar-Apr;56(2):132-135
pubmed: 29901909
Int Dent J. 2007 Jun;57(3):177-83
pubmed: 17695739
PLoS One. 2013;8(2):e56343
pubmed: 23437114
PLoS One. 2013 May 06;8(5):e63139
pubmed: 23671663
Int J Paediatr Dent. 2019 Jul;29(4):448-455
pubmed: 30735595
Lancet. 2020 Apr 4;395(10230):1146-1162
pubmed: 32247396
Zhonghua Er Ke Za Zhi. 2014 Sep;52(9):641-4
pubmed: 25476423
Indian Pediatr. 2008 Jan;45(1):47-51
pubmed: 18250506
Arch Oral Biol. 2015 Sep;60(9):1222-30
pubmed: 26073028
Dent Res J (Isfahan). 2017 May-Jun;14(3):188-194
pubmed: 28702060

Auteurs

Yan Wang (Y)

State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Paediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.

Xinyi Zeng (X)

State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Paediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.

Xue Yang (X)

Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects, Ministry of Education, Sichuan University, Chengdu 610041, China.

Jiajia Que (J)

State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Paediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.

Qin Du (Q)

Department of Stomatology, Sichuan Provincial People's Hospital, Chengdu 610041, China.

Qiong Zhang (Q)

State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Paediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.

Jing Zou (J)

State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Paediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH